The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in rheumatoid arthritis patients tapering tumour necrosis factor inhibitor

Rheumatology (Oxford). 2022 Apr 18;61(SI):SI1-SI3. doi: 10.1093/rheumatology/keab932.

Author

Edoardo Rosato¹

Affiliation

¹ Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.

PMID: 34919664
DOI: 10.1093/rheumatology/keab932

No abstract available

Publication types

Editorial
Comment

MeSH terms

Arthritis, Rheumatoid* / diagnostic imaging
Arthritis, Rheumatoid* / drug therapy
Fluorodeoxyglucose F18*
Humans
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography / methods
Radiopharmaceuticals
Tumor Necrosis Factor Inhibitors

Substances

Radiopharmaceuticals
Tumor Necrosis Factor Inhibitors
Fluorodeoxyglucose F18